---
title: "Sanyuan Biotechnology: Received corrective measures ordered by the Shandong Securities Regulatory Bureau"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230076170.md"
description: "Sanyuan Biotechnology announced that the company and relevant responsible persons received the \"Order for Correction Decision\" and \"Warning Letter Decision\" from the Shandong Securities Regulatory Bureau. Upon investigation, it was found that the company had insufficient basis for selecting indicators such as revenue growth rate, net operating asset growth rate, and discount rate when conducting impairment testing on long-term equity investments at the end of 2023. Some indicators were inappropriately selected, and issues such as not considering the proportion of equity held were identified, violating relevant accounting standards and information disclosure management measures. The Shandong Securities Regulatory Bureau decided to take corrective measures against the company and issued warning letters to Chairman Nie ZaiJian, General Manager Cheng BaoHua, and Chief Financial Officer Yu JunLing"
datetime: "2025-02-28T10:54:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230076170.md)
  - [en](https://longbridge.com/en/news/230076170.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230076170.md)
generator: "portal-rs"
---

# Sanyuan Biotechnology: Received corrective measures ordered by the Shandong Securities Regulatory Bureau

On February 28th, Jinshi Data reported that Sanyuan Biotechnology announced that the company and relevant responsible persons received the "Order for Correction Decision" and "Warning Letter Decision" from the Shandong Securities Regulatory Bureau. Upon investigation, it was found that when the company conducted impairment testing on long-term equity investments at the end of 2023, there were issues such as insufficient basis for selecting indicators like revenue growth rate, net operating asset growth rate, and discount rate, inappropriate selection of some indicators, and failure to consider the proportion of equity held, which violated relevant accounting standards and information disclosure management measures. The Shandong Securities Regulatory Bureau decided to take corrective measures against the company and issued warning letters to Chairman Nie ZaiJian, General Manager Cheng BaoHua, and Chief Financial Officer Yu JunLing

### Related Stocks

- [301206.CN](https://longbridge.com/en/quote/301206.CN.md)

## Related News & Research

- [ZTE signs MoU with BBTEC on AI digital infrastructure projects in Thailand](https://longbridge.com/en/news/297585967.md)
- [Bright Security Expands its AI SDLC security Platform & Launches an AI PT Module](https://longbridge.com/en/news/297648577.md)
- [RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology](https://longbridge.com/en/news/297642626.md)
- [Dataproces logs 7 data analytics agreements in Denmark in August, monthly sales update shows](https://longbridge.com/en/news/297606709.md)
- [Knight Therapeutics wins Colombia approval for Tavalisse in chronic ITP](https://longbridge.com/en/news/297703037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**